Companies / Philippines
Drug Price Controversy Offers Warning To Region
November 2006 | Industry NewsThe state-controlled procurement giant Philippine International Trading Corp (PITC) has claimed that drug prices in the country remain among the highest in the region, with an average four out of five Filipinos unable to afford medicines. Activists such as local lawmaker Senator Manuel Roxas II have claimed that the main reason is the country's intellectual property laws are too
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
